BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33360004)

  • 1. Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors.
    Venkatesh SL; Oseni TO; Bahl M
    Clin Imaging; 2021 May; 73():101-107. PubMed ID: 33360004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study.
    Hsieh YC; Lo C; Lee YH; Chien N; Lu TP; Tsai LW; Wang MY; Kuo WH; Chang YC; Huang CS
    World J Surg Oncol; 2023 Feb; 21(1):48. PubMed ID: 36804000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed-Methods Study to Predict Upstaging of DCIS to Invasive Disease on Mammography.
    Grimm LJ; Neely B; Hou R; Selvakumaran V; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Devalapalli A; Kim C; Soo MS; Hyslop T; Hwang ES; Lo JY
    AJR Am J Roentgenol; 2021 Apr; 216(4):903-911. PubMed ID: 32783550
    [No Abstract]   [Full Text] [Related]  

  • 4. Predicting Upstaging of DCIS to Invasive Disease: Radiologists's Predictive Performance.
    Selvakumaran V; Hou R; Baker JA; Yoon SC; Ghate SV; Walsh R; Litton TP; Lu LX; Devalapalli A; Kim C; Soo MS; Hwang ES; Lo JY; Grimm LJ
    Acad Radiol; 2020 Nov; 27(11):1580-1585. PubMed ID: 32001164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical ductal hyperplasia on core biopsy: an automatic trigger for excisional biopsy?
    McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
    Ann Surg Oncol; 2012 Oct; 19(10):3264-9. PubMed ID: 22878619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Upstaging in Ductal Carcinoma in Situ Based on Mammographic Radiomic Features.
    Hou R; Grimm LJ; Mazurowski MA; Marks JR; King LM; Maley CC; Lynch T; van Oirsouw M; Rogers K; Stone N; Wallis M; Teuwen J; Wesseling J; Hwang ES; Lo JY
    Radiology; 2022 Apr; 303(1):54-62. PubMed ID: 34981975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
    Si J; Guo R; Huang N; Xiu B; Zhang Q; Chi W; Wu J
    Cancer Med; 2019 Dec; 8(18):7586-7593. PubMed ID: 31660702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
    Harowicz MR; Saha A; Grimm LJ; Marcom PK; Marks JR; Hwang ES; Mazurowski MA
    J Magn Reson Imaging; 2017 Nov; 46(5):1332-1340. PubMed ID: 28181348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
    Yoo J; Kim BS; Yoon HJ
    Ann Nucl Med; 2018 Jun; 32(5):328-336. PubMed ID: 29556944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
    Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
    Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
    Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
    Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.
    Tanaka K; Masuda N; Hayashi N; Sagara Y; Hara F; Kadoya T; Matsui A; Miyazaki C; Shien T; Tokunaga E; Hayashi T; Niikura N; Maeda S; Komoike Y; Bando H; Kanbayashi C; Iwata H
    Breast Cancer; 2021 Jul; 28(4):896-903. PubMed ID: 33599914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with upstaging of ductal carcinoma in situ diagnosed by core needle biopsy using imaging guidance.
    Wiratkapun C; Patanajareet P; Wibulpholprasert B; Lertsithichai P
    Jpn J Radiol; 2011 Oct; 29(8):547-53. PubMed ID: 21927996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperatively diagnosed ductal cancers in situ of the breast presenting as even small masses are of high risk for the invasive cancer foci in postoperative specimen.
    Szynglarewicz B; Kasprzak P; Halon A; Matkowski R
    World J Surg Oncol; 2015 Jul; 13():218. PubMed ID: 26179898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
    Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
    Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Lehman CD; Oseni TO; Bahl M
    Acad Radiol; 2020 Oct; 27(10):1394-1399. PubMed ID: 31699638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ.
    Lee SA; Lee Y; Ryu HS; Jang MJ; Moon WK; Moon HG; Lee SH
    Radiology; 2022 Nov; 305(2):307-316. PubMed ID: 35787199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.